TCL Archive FDA examining endpoints for approval of cancer therapies, potential departure from survival as the gold standard, Oncology Division Director Richard Pazdur says in interview. November 7, 2003
TCL Archive Bypass Budget for FY 1989 to Ask $2 Billion For NCI, With Projection To $3 Billion by 1993 May 29, 1987
TCL Archive Taxol Plus Carboplatin Increased Survival Of NSCLC In Patients 70 And Older June 25, 2010
TCL Archive In Brief: Weicker Heads New Group For More Spending On Medical Research; Committee Oks Sullivan March 3, 1989
